MEDICAN ENTERPRISES, INC. Inactive Instrument
Medican Enterprises, Inc. Share Price Other OTC
Equities
MDCN
US58464T2024
Pharmaceuticals
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2013 | - | Sales 2014 | - | Capitalization | 7L 5.51Cr |
|---|---|---|---|---|---|
| Net income 2013 | - 0 | Net income 2014 | -5.6Cr -467.39Cr | EV / Sales 2013 | - |
| Net Debt 2013 | 1L 97.26L | Net Debt 2014 | 58.46L 49Cr | EV / Sales 2014 | - |
| P/E ratio 2013 |
-21.9
x | P/E ratio 2014 |
-0.01
x | Employees | - |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Mitchell Xavier
CEO | Chief Executive Officer | - | - |
Kenneth Williams
CHM | Chairman | 52 | 25/13/25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kenneth Williams
CHM | Chairman | 52 | 25/13/25 |
Medican Enterprises, Inc. is engaged in residential and commercial real estate investment and development. The Company has relationships with equity suppliers, such as individual, commercial and institutional sources. The Company is specialized in value-added investment and development in A location in urban infill areas. The Companyâs subsidiary, Immediate Properties LLC, is a real estate company. Immediate Properties LLC is engaged in multifamily, retail, office, mixed-use, adaptive re-use of industrial buildings and historic renovations. Its investment portfolio includes properties across Northern and Southern California, Atlanta, and Nevada. The Company invests in California and other select metro areas.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +32.36% | 71TCr | |
| +30.77% | 60TCr | |
| -1.60% | 37TCr | |
| +20.07% | 33TCr | |
| +6.04% | 29TCr | |
| +14.77% | 24TCr | |
| +9.13% | 21TCr | |
| -3.97% | 20TCr | |
| +9.27% | 17TCr |
